相关实验视频

Updated: Sep 19, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

在非小细胞肺癌的新分期系统中,[¹⁸F]氧糖PET/CT的预后值为[¹⁸F]氧糖PET/CT

Wonseok Whi¹, Hyunjong Lee¹, Sang-Won Um²

¹Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

European radiology

|June 19, 2025

概括

主要瘤[18F]氧葡萄糖 (FDG) 吸收,以SUVmax计量,是非小细胞肺癌 (NSCLC) 的显著预后因素. 将SUVmax集成到第九届AJCC/UICC分阶段系统中可以提高预测准确性和风险分层.

科学领域:

在瘤学瘤学.
核医学就是核医学.
无线电学 (Radiomics) 是一种无线电学.

背景情况:

美国癌症联合委员会 (AJCC) /国际癌症控制联盟 (UICC) 非小细胞肺癌 (NSCLC) 阶段系统的第九版不包含代谢信息.
通过[18F]氧葡萄糖 (FDG) 的摄入来评估瘤代谢,可能提供额外的预后价值.

研究的目的:

评估一次性瘤FDG吸收 (SUVmax) 在接受治疗治疗的NSCLC患者的预后意义.
评估SUVmax在纳入第九版AJCC/UICC NSCLC分期系统时的附加值.

主要方法:

对3070名接受治疗前FDG PET/CT的NSCLC患者的回顾性分析.
使用单变量和多变量模型进行生存分析 (总体和无疾病生存率).
将SUVmax与传统分阶段系统相比拟的分阶段系统的比较.

主要成果:

主要瘤SUVmax是NSCLC总体和无病生存的独立预后因素.
将SUVmax集成到分阶段系统中,改善了预后分层,特别是在中间阶段 (例如IIA和IIB).
与传统系统相比,拟议的分期系统显示出更高的预后准确性.

结论:

主要瘤FDG吸收 (SUVmax) 在NSCLC中提供了重要的预后信息.
将SUVmax纳入第九届AJCC/UICC分阶段系统可以提高其风险分层的准确性.
这些代谢信息使得NSCLC患者的预后更精确.

关键词:

非小细胞肺癌是非小细胞肺癌.定子发射断层扫描 (PET) 是一种定子发射断层扫描.预测预后预后进行分期,分期.[18F]氧化葡萄糖.

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Management of Respiratory Motion Artefacts in 18F-fluorodeoxyglucose Positron Emission Tomography using an Amplitude-Based Optimal Respiratory Gating Algorithm

Published on: July 23, 2020

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...